| The Developemnt of Vascular System | |
| Embryonic Development of Blood Vessels | p. 1 |
| Regulation of Embryonic Blood Vessel Formation | p. 17 |
| Role of Heterotypic Interactions between Endothelial Cells and Parenchymal Cells in Organospecific Differentiation: A Possible Trigger of Vasculogenesis | p. 27 |
| Role of the Macrophage in the Regulation of Physiological and Pathological Angiogenesis | p. 43 |
| Biology of Endothelial Cells and Angiogenesis | |
| Endothelial Cell Heterogeneity and Differentiation | p. 55 |
| Heterogeneity in Endothelial Cells with Special Reference to their Growth Related Proteins | p. 63 |
| Basic Fibroblast Growth Factor and Endothelial Cells: Receptor Interaction, Signal Transduction, Cellular Response--Dissociation of the Mitogenic Activity of bFGF from its Plasminogen Activator Inducing Capacity | p. 79 |
| Role of Integrins in Endothelial Cell Function | p. 91 |
| Specific Laminin Domains Mediate Endothelial Cell Adhesion, Alignment and Angiogenesis | p. 99 |
| Production of Plasminogen Activators and Matrix Metalloproteinases by Endothelial Cells: Their Role in Fibrinolysis and Local Proteolysis | p. 111 |
| Heparin Coordinately Suppresses Endothelial Cell Plasminogen Activator Inhibitor-1, Fibronectin and Thrombospondin mRNA Levels | p. 127 |
| Properties of Endothelial Cells and Smooth Muscle Cells Grown in 3-Dimensional Collagen Lattices | p. 135 |
| Effect of Ischaemia on Endothelial Cells | p. 143 |
| Angiogenesis in Disease States | |
| Angiogenesis and Neoplastic Transformation | p. 149 |
| Vascular Proliferation in Tumors and its Influence on Cancer Therapy | p. 157 |
| The Development of the Tumor Vascular System: 2-D and 3-D Approaches to Network Formation in Human Xenografted Tumours | p. 173 |
| Tumor Induced Angiogenesis: Effect of Platelet Derived Growth Factor (PDGF), Pentoxifylline, Sodium Diethyldithiocarbamate, Epsilon Amino Caproic Acid and Tranexamic Acid | p. 185 |
| Vascular Growth in the Intermittently Ischemic Heart: A Study on Growth Factors Expression | p. 195 |
| Role of Mechanical Factors in Angiogenesis under Physiological and Pathophysiological Circumstances | p. 207 |
| Low Molecular Mass Non-Protein Angiogenic Factors and their Role in the Disease Processes | p. 217 |
| Calcification-Linked Angiogenesis and Bone Growth | p. 231 |
| Promoters and Inhibitors of Angiogenesis | |
| Involvement of Low Molecular Mass Angiogenic Factor (ESAF) in the Activation of Latent Matrix Metalloproteinases | p. 243 |
| Hyaluronic Acid Promotes and Inhibits Angiogenesis | p. 253 |
| Brain Tumor Angiogenesis: Drug Delivery and New Inhibitors | p. 265 |
| Evaluation of Promoters and Inhibitors of Angiogenesis Using Basement Membrane Biosynthesis as an Index | p. 275 |
| Therapeutic Potential of Promoters and Inhibitors of Angiogenesis | |
| On Promoters of Angiogenesis and Therapeutic Potential | p. 287 |
| The Development of Therapeutic Angiosuppression: Problems and Progress | p. 295 |
| Anti-Angiogenic Versus Anti-Vascular Approaches to Cancer Therapy | p. 303 |
| Methodology | |
| Assays for Angiogenic Factors | p. 307 |
| Development and Validation of a Sponge Model for Quantitative Studies on Angiogenesis | p. 317 |
| New Approaches to the Measurement of Proliferation Rates | p. 333 |
| Factitious Angiogenesis: Endothelialization of Artificial Cardiovascular Prostheses | p. 339 |
| Abstracts of Oral and Poster Presentations | p. 353 |
| Participants | p. 395 |
| Index | p. 401 |
| Table of Contents provided by Blackwell. All Rights Reserved. |
